COVID-19 THERAPEUTIC INTERVENTIONS
dc.contributor.advisor | Bombicz, Mariann | |
dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | |
dc.contributor.author | AYMAN MOHAMED ALY, MAYAR | |
dc.contributor.department | DE--Általános Orvostudományi Kar | |
dc.contributor.opponent | Siposné Fehér, Pálma | |
dc.contributor.opponent | Varga , Balázs | |
dc.contributor.opponentdept | Debreceni Egyetem::Gyógyszerésztudományi Kar::Gyógyszertechnológiai Tanszék | |
dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | |
dc.date.accessioned | 2023-07-20T08:26:57Z | |
dc.date.available | 2023-07-20T08:26:57Z | |
dc.date.created | 2023 | |
dc.description.abstract | This thesis sets a strategic severity based therapeutic approach to COVID-19. Amidst the several drugs that have been used since the start of COVID-19, this literature clarifies which of these drugs are truly effective and in which cases to use them. It also highlights the ineffective drugs as an approach to limit their use in the management of COVID-19 patients. Moreover, this literature establishes a comprehensive and time-critical scheme for the treatment of COVID-19. | |
dc.description.course | általános orvos | |
dc.description.courselang | angol | |
dc.description.degree | egységes, osztatlan | |
dc.format.extent | 41 | |
dc.identifier.uri | https://hdl.handle.net/2437/357713 | |
dc.language.iso | en | |
dc.subject | COVID-19 | |
dc.subject | THERAPEUTIC APPROACH | |
dc.subject | NEW DRUGS | |
dc.subject | ANTIVIRAL | |
dc.subject | IMMUNO-MODULATORS | |
dc.subject | VACCINATION | |
dc.subject.dspace | DEENK Témalista::Orvostudomány | |
dc.title | COVID-19 THERAPEUTIC INTERVENTIONS |